sb 203580 has been researched along with Leucocythaemia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (85.71) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, Z; Lu, S; Ma, F; Ren, Q; Tian, K; Yang, S; Zhang, L | 1 |
Araragi, S; Higashimoto, M; Kondoh, M; Sato, M; Takiguchi, M; Tasaki, E; Watanabe, Y | 1 |
Dent, P; Grant, S; Rahmani, M; Yu, C | 1 |
Gocek, E; Kiełbiński, M; Marcinkowska, E | 1 |
Caravatta, L; Cataldi, A; di Giacomo, V; Di Pietro, R; Rana, R; Sancilio, S | 1 |
Berger, F; Champelovier, P; El Atifi, M; Pautre, V; Rostaing, B; Seigneurin, D | 1 |
Fan, C; Liu, G; Liu, RY; Olashaw, NE; Zuckerman, KS | 1 |
7 other study(ies) available for sb 203580 and Leucocythaemia
Article | Year |
---|---|
p38 MAPK contributes to the growth inhibition of leukemic tumor cells mediated by human umbilical cord mesenchymal stem cells.
Topics: Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Humans; Imidazoles; Leukemia; Mesenchymal Stem Cells; Mitogen-Activated Protein Kinase 14; Phosphorylation; Pyridines; RNA Interference; RNA, Small Interfering; Signal Transduction; Umbilical Cord | 2010 |
Requirement of caspase and p38MAPK activation in zinc-induced apoptosis in human leukemia HL-60 cells.
Topics: Apoptosis; Blotting, Western; Caspases; Cell Death; Cell Line; Dose-Response Relationship, Drug; Enzyme Inhibitors; HL-60 Cells; Humans; Imidazoles; In Situ Nick-End Labeling; Ionophores; Leukemia; Mitogen-Activated Protein Kinases; Necrosis; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Thiones; Time Factors; Zinc | 2002 |
The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib.
Topics: Anthracenes; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Caspases; Cytochromes c; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Leukemia; MAP Kinase Signaling System; Membrane Potentials; Mitochondria; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Models, Biological; Protease Inhibitors; Pyrazines; Pyridines; Reactive Oxygen Species; Signal Transduction; U937 Cells | 2004 |
Activation of intracellular signaling pathways is necessary for an increase in VDR expression and its nuclear translocation.
Topics: Active Transport, Cell Nucleus; Calcitriol; Cell Nucleus; Cells, Cultured; Chromones; Enzyme Inhibitors; Fatty Acids, Unsaturated; Flavonoids; Gene Expression Regulation; HL-60 Cells; Humans; Imidazoles; Leukemia; Models, Biological; Morpholines; Protein Biosynthesis; Pyridines; Receptors, Calcitriol; Signal Transduction | 2007 |
PI3-K/Akt-dependent activation of cAMP-response element-binding (CREB) protein in Jurkat T leukemia cells treated with TRAIL.
Topics: Apoptosis; Caspase 3; Cell Culture Techniques; Chromones; Clone Cells; Cyclic AMP Response Element-Binding Protein; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Histidine; Humans; Imidazoles; Indoles; Jurkat Cells; Leukemia; Morpholines; Necrosis; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Recombinant Proteins; RNA, Small Interfering; T-Lymphocytes; TNF-Related Apoptosis-Inducing Ligand; Transfection | 2008 |
Specific inhibition of basal mitogen-activated protein kinases and phosphatidylinositol 3 kinase activities in leukemia cells: a possible therapeutic role for the kinase inhibitors.
Topics: Anthracenes; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Differentiation; Cell Division; Cell Line, Tumor; Chromones; Drug Screening Assays, Antitumor; Drug Synergism; Flavonoids; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Imidazoles; Leukemia; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Monocytes; Morpholines; Neoplasm Proteins; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Pyridines; U937 Cells | 2008 |
Activation of p38 mitogen-activated protein kinase is required for tumor necrosis factor-alpha -supported proliferation of leukemia and lymphoma cell lines.
Topics: Cell Division; Cell Nucleus; Cell Survival; Enzyme Activation; Enzyme Inhibitors; Genes, Reporter; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Imidazoles; Kinetics; Leukemia; Lymphoma; Mitogen-Activated Protein Kinases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyridines; Recombinant Proteins; Signal Transduction; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |